Koers Advanced Accelerator Application SA(ADR)

Aandelen

slotkoers Nasdaq Andere beurzen
-	-

Advanced Accelerator Applications signs exclusive option and license agreement with FUJIFILM Toyama Chemical to develop and commercialize radiolabeled FF-10158 for oncology indications	03-12-18
Advanced Accelerator Applications Signs Exclusive License Agreement with Cancer Targeted Technology to Develop CTT1057, an F-18 Labeled PSMA Ligand for Diagnostic Applications in Prostate Cancer	12-02-18
Advanced Accelerator Applications Announces Completion of Subsequent Offering Period for Novartis Tender Offer	01-02-18
Advanced Accelerator Applications Receives US FDA Approval for LUTATHERA® for Treatment of Gastroenteropancreatic Neuroendocrine Tumors	26-01-18
Advanced Accelerator Applications Announces Completion of $3.9 Billion Novartis Tender Offer	22-01-18

Managers	Titel	Leeftijd	Van
Caio Kugelmas DFI	Director of Finance/CFO	-	-
Sidonie Roswitha Golombowski-Daffner CHM	Chairman	-	01-10-19
Ute Simon CTO	Chief Tech/Sci/R&D Officer	-	01-04-20

Besturend	Titel	Leeftijd	Van
Frédéric Collet BRD	Director/Board Member	-	01-01-18
Jessica Toepfer BRD	Director/Board Member	-	01-01-18
Sidonie Roswitha Golombowski-Daffner CHM	Chairman	-	01-10-19

Sector

	Vaira. 1 jan.	Kapi.
MERCK KGAA	+5,31%	70,44 mld.
KYOWA KIRIN CO. LTD.	+10,97%	8,94 mld.
SK BIOPHARMACEUTICALS CO., LTD.	-16,83%	4,75 mld.
SHENYANG XINGQI PHARMACEUTICAL CO.,LTD.	+43,48%	4,5 mld.
YUHAN CORPORATION	+3,20%	3,85 mld.
BETTA PHARMACEUTICALS CO., LTD.	-21,36%	2,34 mld.
CHANGCHUN BCHT BIOTECHNOLOGY CO.	-29,67%	2,2 mld.
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD.	+8,38%	1,96 mld.
SUPERNUS PHARMACEUTICALS, INC.	+3,90%	1,65 mld.